Pura Vida Investments, LLC Syndax Pharmaceuticals Inc Call Options Transaction History

Pura Vida Investments, LLC

  • $151 Million
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 14, 2019
SELL
$4.26 - $6.86 $471,582 - $759,402
-110,700 Closed
0 $0
Q4 2018

Feb 11, 2021
BUY
$3.6 - $8.42 $394,534 - $922,773
109,593 Added 9900.0%
110,700 $493,000
Q4 2018

Feb 14, 2019
SELL
$3.6 - $8.42 $356,014 - $832,679
-98,893 Reduced 98.89%
1,107 $6,000
Q3 2018

Feb 11, 2021
BUY
$6.33 - $8.08 $626,670 - $799,920
99,000 Added 9900.0%
100,000 $808,000
Q3 2018

Nov 14, 2018
BUY
$6.33 - $8.08 $6,330 - $8,080
1,000 New
1,000 $215,000

Others Institutions Holding SNDX

# of Institutions
202
Shares Held
87.1M
Call Options Held
268K
Put Options Held
76.8K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.07B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email